Diabetic Retinopathy Epidemiology Forecast Report 2021-2030 – ResearchAndMarkets.com | Financial Buzz

Diabetic Retinopathy Epidemiology Forecast Report 2021-2030 – ResearchAndMarkets.com

The “Diabetic Retinopathy – Epidemiology Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering.

The total prevalent cases of Diabetic Retinopathy patients are increasing in 7MM during the study period, i.e. 2018-2030.

The report includes the prevalent scenario of Diabetic Retinopathy symptoms in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2018 to 2030.

The disease epidemiology covered in the report provides historical as well as forecasted Diabetic Retinopathy symptoms epidemiology segmented as the Total Diagnosed Prevalent cases of Diabetic Retinopathy, Gender-specific cases of Diabetic Retinopathy, Age-specific cases of Diabetic Retinopathy, and Severity-specific cases of Diabetic Retinopathy.

Country Wise- Diabetic Retinopathy Epidemiology

  • The total diagnosed cases of Diabetic Retinopathy associated in 7MM countries were 8,033,083 in 2020.
  • As per the estimates, the United States has the largest diagnosed population of Diabetic Retinopathy.
  • Among the European countries, in 2020, Germany had the highest population of diabetic retinopathy with 2,167,200 cases, followed by Italy, which had 1,485,668 cases. On the other hand, the UK had the lowest number of cases 855,039 in 2020.
  • In 2020, diagnosed prevalent cases of diabetic retinopathy in the US varied according to gender; 2,181,806 and 2,190,498 cases for females and males, respectively, which are likely to increase in the forecast period.
  • Age plays an important role in diabetic retinopathy as it is most common in the older population. In 2020, there were 1,632,516 cases in the age group 50-64 and 354,420 cases in the age group 30-39, which are likely to rise by 2030 in the US.

Scope of the Report

  • The Diabetic Retinopathy report covers a detailed overview explaining its causes, symptoms, and classification, pathophysiology, diagnosis, and treatment patterns.
  • The Diabetic Retinopathy Epidemiology Report and Model provide an overview of the risk factors and 7MM trends of Diabetic Retinopathy in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
  • The report provides insight into the historical and forecasted patient pool of Diabetic Retinopathy in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
  • The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
  • The report assesses the disease risk and burden and highlights the unmet needs of Diabetic Retinopathy.
  • The report provides the segmentation of the Diabetic Retinopathy epidemiology by Diagnosed Cases of Diabetic Retinopathy in 7MM.
  • The report provides the segmentation of the Diabetic Retinopathy epidemiology by Gender-Specific Diagnosed Prevalent Cases of Diabetic Retinopathy in 7MM.
  • The report provides the segmentation of the Diabetic Retinopathy epidemiology by Age-Specific Diagnosed Prevalent Cases of Diabetic Retinopathy in 7MM.
  • The report provides the segmentation of the Diabetic Retinopathy epidemiology by Severity-Specific Diagnosed Prevalent Cases of Diabetic Retinopathy in 7MM.

Key Topics Covered:

1 Key Insights

2 Executive summary

3 Organizations

4 Diabetic Retinopathy: Overview at a Glance

4.1 Introduction

4.2 Diabetes Mellitus

4.2.1 Type 1 Diabetes Mellitus

4.2.2 Type 2 Diabetes Mellitus

4.3 Pathophysiology

4.4 Clinical Presentation

4.5 Diabetic Retinopathy Symptoms

4.6 Diabetic Retinopathy Risk Factors

4.7 Diabetic Retinopathy Classification

4.8 Diagnosis of Diabetic Retinopathy

5 Epidemiology and Patient Population

5.1 Key Findings

5.2 Assumptions and Rationale

5.3 Total cases of Diabetic Retinopathy in the 7MM

5.4 United States

5.4.1 Total Diagnosed cases of Diabetic Retinopathy in the United States

5.4.2 Gender-specific cases of Diabetic Retinopathy in the United States

5.4.3 Age-specific cases of Diabetic Retinopathy in the United States

5.4.4 Severity-specific cases of Diabetic Retinopathy in the United States

5.5 EU5 Countries

5.5.1 Germany

5.5.2 France

5.5.3 Italy

5.5.4 Spain

5.5.5 United Kingdom

5.6 Japan

6 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/v1qze0

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!